Abstract
Effective, accurate, and rapid diagnostic tools for detecting SARS-Covid2 infection are urgently needed to prevent and control the pandemic. While RT-qPCR is a gold standard test for diagnosing SARS-Covid2 infections, this method is limited by the requirement for expensive equipment, experienced staff and specialized molecular laboratory. Recently, the CRISPR cas13 platform was used for the detection of COVID-19. This study evaluated the clinical performance of the CRISPRbased cas13a diagnostic assay for SARS-Covid2. In the current study, the diagnostic performance of the Cas13-based SHERLOCK (Specific High Sensitivity Enzymatic Reporter Unlocking) assay was compared with RT-qPCR in terms of sensitivity, specificity and time consumption. Keywords: Crispr-Cas13; Covid-19; Sherlock
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
